Emerging role of adenosine in brain disorders and amyotrophic lateral sclerosis
Credit: Mary Ann Liebert, Inc publishers
New Rochelle, NY, December 6, 2019 -The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine...
Authors take in-depth look at risks associated with medical AI/ML systems
Artificial intelligence and machine learning (AI/ML) are increasingly transforming the healthcare sector. From spotting malignant tumours to reading CT scans and mammograms, AI/ML-based technology is faster and more accurate than traditional devices - or...
$70M from Sidney and Caroline Kimmel to Fund Thomas Jefferson U. Cancer Research Building
Caroline and Sidney Kimmel
Philanthropists Sidney and Caroline Kimmel have gifted $70 million to Thomas Jefferson University toward construction of a new research building that is intended to enhance “big ideas” research at its Sidney...
The growth of biotechnology and service Outsourcing network – Industry Global News 24
Healthcare4 Min read
The growth of biotechnology and service Outsourcing network
Published On 06 Dec 2019 02:40 PM
SHARE THIS ARTICLE
In Australia, can be clearly noticed that the growth of biotechnology...
Update: Cancer Immunotherapy Biotech Files for Insolvency
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in the summer, the German company Mologen has filed for insolvency.
Published 06/08/2019
A DNA immunotherapy drug developed by the German company...
Polyplus-transfection expands GMP portfolio to provide additional flexibility for gene and cell therapy developers
Dec 6 2019
Polyplus-transfection(R) SA, the leading biotechnology company that supports gene and cell therapy by supplying innovative transfection solutions, today announces the availability of the first GMP-grade transfection reagent PEIpro(R)-GMP in additional conditioning that...
First investigational drug therapy for liver disease NASH awaiting FDA approval
Global clinical trial designed in collaboration with VCU successfully tested a drug therapy to treat NASH, a chronic liver disease and the fastest-growing reason for liver transplantation in the U.S.
Credit: Virginia Commonwealth University
German Biotech Raises €7M Series A to Treat Acute Heart Failure
4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of a first-in-class antibody drug that could reduce mortality in acute heart failure.
The round was led by Brandenburg Kapital, a...
Smart, self-powered patch to put an end to €2.3 trillion bill caused by rust...
The cost of corrosion runs to 3-4% of the gross world product annually, and therefore there is increasing focus on monitoring infrastructure; Danish researchers are developing a smart patch that can cut huge amounts...
Biotechnology Market is set to garner staggering revenues by 2017 – 2025 – Hitz...
International Biotechnology Market Research
The new document printed by TMRR at the world Biotechnology marketplace is an in-intensity research of the entire potentialities of the Biotechnology marketplace within the upcoming years. The knowledge...
